Company: FEAV
Filing Date: 2025-05-23
Form Type: S-3
Source: 0001193125-25-125840
Chunk: 11

Company: 5E Advanced Materials, Inc.
Filing Date: 2025-05-23
Form: S-3
Chunk 11
---
1 of
the Australian Corporations Act, 2001 (Cth), we listed our common stock on The Nasdaq Global Select Market (“Nasdaq”) and de-listed ABR from the ASX in March 2022. In connection with a series of out-of-court restructuring transactions consummated in January 2024, we issued shares of our common stock and CHESS Depositary Interests, each representing an interest in one-tenth of a share of our common stock (“CDIs”), to ABR’s shareholders, and ABR became our wholly owned subsidiary.

Our principal executive offices are located at 9329 Mariposa Road, Ste 210, Hesperia, CA 92344 and our telephone number is (442) 221-0225. Our website address is http://www.5eadvancedmaterials.com. The information contained on, or that can be accessed through, our website is not incorporated by referenced into this prospectus and does not
constitute a part of this prospectus. We have included our website address in this prospectus solely as an inactive textual reference.

7

THE OFFERING

| Issuer | 5E Advanced Materials, Inc. |

| Shares of common stock that may be offered and sold from time to time by the Selling Stockholders named 
 herein                                                                                                  | 2,021,751 shares (the “Shares”) of common stock, par value of $0.01 per share. |

| Use of proceeds | We will not receive any of the proceeds from the sale of the Shares by the Selling Stockholders. |

| Market for our common stock | Our common stock is listed on Nasdaq under the symbol “FEAM.” |

| Risk Factors | Any investment in the securities offered hereby is speculative and involves a high degree of risk. You should carefully read and consider the information set forth under “Risk Factors” on page 9 of this prospectus. |

8

RISK FACTORS

Investing in our securities involves risks. You should carefully consider the risk factors incorporated by reference to our most recent Annual
Report on Form 10-K, and any subsequent Quarterly Reports on Form 10-Q or Current Reports on Form 8-K, and all other information
contained or incorporated by reference into this prospectus, as updated by our subsequent filings under the Exchange Act (including amendments to the foregoing), and the risk factors and other information contained in any applicable prospectus
supplement or free writing prospectus before acquiring any of such securities. The